![](https://sdbn.org/wp-content/uploads/2021/11/Asset-9@4x.png)
TAIPEI and SAN DIEGO, Dec. 26, 2023 /PRNewswire/ — Senhwa Biosciences, Inc. (TPEx: 6492), a drug development company focusing on first-in-class therapeutics for oncology, rare diseases, and infectious diseases, announced today that Taiwan Food and [...]